{"name":"Longbio Pharma","slug":"longbio-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-02","type":"trial","source":"The Manila Times","summary":"Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair® - The Manila T","headline":"Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPUWhGOURyWUgzRTVDQm9OdnUtS3VPR3Z5WEZQaXlpdU4yb1ByRkwzcWtycGsyM3RnV1czd0h5aENuWHBKX3Z2bVEzZ2hCOHdZSWZLMlVGQTJuQ3FCNGR3T3lZVlJiNkVQOGNKYnZVbzNxdnBDZS14bXlWcTJLclRvdW5qNUpNWDV0ampV?oc=5","date":"2026-01-05","type":"pipeline","source":"Longevity.Technology","summary":"Why LongBio is poised for a breakout at JPM 2026 - Longevity.Technology","headline":"Why LongBio is poised for a breakout at JPM 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9oZ3NtX3lPdUs5cGUwUUdSdE1HWXJ1VnpoQ3FFVUVzcDhlcDU0dWR4bFR2SU9qY2pPeFEzejFXWmdJNkdrY21PTFVsUHlpTmlVRTV1dVpsZzI?oc=5","date":"2025-08-07","type":"deal","source":"启明创投","summary":"Qiming Venture Partners Newsletter – June 2025 - 启明创投","headline":"Qiming Venture Partners Newsletter – June 2025 - 启明创投","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"prnewswire.com","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - prnewswire.com","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxOdERkUXowYm91d0VKWWo0SlBSWktzaGZwM3RJdm9kV0t1ZnhpZUFiVENMRmdJOWtUNXV6WmJZMEpBN3Q1X2d2TXFXOEEzNTZhRjd0N2E4Z1paRnVPenBtNllvT2JmbjBndUdTNGNpam83OGRrZDlGdVVNMWp0dHZ4SHRKb3hXMzBzN3Qxd01XQ1pmYVpDbkFpSWRaVGc4YUI0alViSW1xYjUzNXJDd3FwUlJRRktEdDVmU1BwYzJQNUpCYlVpbDdjeDVyMEMwYUlBUVZsZW1jSkRYMVhxMUU0UVN4R1luNDlfRVoxLWRDWm9NV3R5WTByRlRLTTNKeldweUhUSzNfZUs?oc=5","date":"2024-11-04","type":"trial","source":"GlobeNewswire","summary":"Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire","headline":"Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOQW9vSFctSFphNXMxdlI1UW5WTEt4azlpYV8td0YwanZtcWZBaGdNRWN5cDE3bTZuODlsT0ZSWEY5UlB6bndfaDVDakU1QkdpT2V5SXhhYUIxZW1nb3lBa0w5WXQ5WmlYN0ZHTGFjV2kyWXVpQlRnR3RaOHlyeVc2akFtYkxHRmloaUlWam45bU02dWdNbVotcUhXcmhaeU5zQ2k2WVM0MktsUHNFbjVVT0ZJSTFlRDRUSmxWc1czUEhSWTVDYnRnNzlSX3BFSnd0NHF4WjczdnlIT0xyT3M3dVRUN25KVWt6UmJBMW5HMA?oc=5","date":"2024-09-25","type":"pipeline","source":"BioSpectrum Asia","summary":"Chinese biotech startup LongBio Pharma completes Series B2 financing to advance late-stage clinical studies - BioSpectrum Asia","headline":"Chinese biotech startup LongBio Pharma completes Series B2 financing to advance late-stage clinical studies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE95YWp3Z19OYXlxR1ZRdS1fLTdiUUNURDh5Y1dFNHZvWkVYaHg4UU5FYU5BUGRFaEhrR3otR2JMMFVqT1RNZTFqaGtHek1OM2lmaUZPNzBRVDNNZjZUVTFmVm16b1NhSFlBTHZ5YTJkdmh1eGJubDRMQTZud28?oc=5","date":"2023-06-20","type":"trial","source":"Clinical Trials Arena","summary":"Longbio reports positive data from allergic rhinitis therapy trial - Clinical Trials Arena","headline":"Longbio reports positive data from allergic rhinitis therapy trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBoUHh6V3I1clFlUHFtajJmZWdRZW50dGN4aklhU0lKTDFOLU80a1BwTU1ra3d4QlhrSE9nMVR4WlNwVEEzZ1o3UXZqVHMtc0tGU3VldWRkdlZSRFQyalI5OHBTcU91cjZ3?oc=5","date":"2014-12-19","type":"pipeline","source":"Mad In America","summary":"Robert Berezin, MD – Long Bio - Mad In America","headline":"Robert Berezin, MD – Long Bio","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}